1-11 of 11
myelofibrosis, idiopathic, chronic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Aaron T. Gerds
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 407–414.
https://doi.org/10.1182/hematology.2019000048
Published: 2019
Journal Articles

The spectrum of JAK2-positive myeloproliferative neoplasms

Jean-Jacques Kiladjian
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 561–566.
https://doi.org/10.1182/asheducation.V2012.1.561.3807838
Published: 2012
Journal Articles

Is there a role for the use of IFN-α in primary myelofibrosis?

Huong (Marie) Nguyen, Jean-Jacques Kiladjian
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 567–570.
https://doi.org/10.1182/asheducation.V2012.1.567.3806899
Published: 2012
Journal Articles

World Health Organization Classification, Evaluation, and Genetics of the Myeloproliferative Neoplasm Variants

James Vardiman, Elizabeth Hyjek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 250–256.
https://doi.org/10.1182/asheducation-2011.1.250
Published: 2011
Journal Articles

Pathogenesis and management of essential thrombocythemia

Philip A. Beer, Anthony R. Green
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 621–628.
https://doi.org/10.1182/asheducation-2009.1.621
Published: 2009
Journal Articles

Therapeutic potential of JAK2 inhibitors

Srdan Verstovsek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 636–642.
https://doi.org/10.1182/asheducation-2009.1.636
Published: 2009
Journal Articles

New Advances in the Pathogenesis and Therapy of Essential Thrombocythemia

Ross L. Levine, Mark Heaney
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 76–82.
https://doi.org/10.1182/asheducation-2008.1.76
Published: 2008
Journal Articles

Navigating the Evolving Paradigms in the Diagnosis and Treatment of Myeloproliferative Disorders

Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 355–362.
https://doi.org/10.1182/asheducation-2007.1.355
Published: 2007
Journal Articles

Biology and Treatment of Primary Myelofibrosis

Ronald Hoffman, Damiano Rondelli
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 346–354.
https://doi.org/10.1182/asheducation-2007.1.346
Published: 2007
Journal Articles

A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative Diseases

William Vainchenker, Stefan N. Constantinescu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 195–200.
https://doi.org/10.1182/asheducation-2005.1.195
Published: 2005
Journal Articles

Chronic Myeloproliferative Disorders

Jerry L. Spivak, Giovanni Barosi, Gianni Tognoni, Tiziano Barbui, Guido Finazzi, Roberto Marchioli, Monia Marchetti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 200–224.
https://doi.org/10.1182/asheducation-2003.1.200
Published: 2003